Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Metabolism

Prohibitin Overexpression in Adipocytes Induces Mitochondrial Biogenesis, Leads to Obesity Development, and Affects Glucose Homeostasis in a Sex-Specific Manner

  1. Sudharsana R. Ande1,
  2. K. Hoa Nguyen1,
  3. G. Pauline Padilla-Meier1,
  4. Wahida Wahida1,
  5. B.L. Grégoire Nyomba1,2 and
  6. Suresh Mishra1,2⇑
  1. 1Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
  2. 2Department of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada
  1. Corresponding author: Suresh Mishra, suresh.mishra{at}med.umanitoba.ca.
  1. S.R.A. and K.H.N. contributed equally to this article.

Diabetes 2014 Nov; 63(11): 3734-3741. https://doi.org/10.2337/db13-1807
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Abstract

Adipocytes are the primary cells in the body that store excess energy as triglycerides. To perform this specialized function, adipocytes rely on their mitochondria; however, the role of adipocyte mitochondria in the regulation of adipose tissue homeostasis and its impact on metabolic regulation is not understood. We developed a transgenic mouse model, Mito-Ob, overexpressing prohibitin (PHB) in adipocytes. Mito-Ob mice developed obesity due to upregulation of mitochondrial biogenesis in adipocytes. Of note, Mito-Ob female mice developed more visceral fat than male mice. However, female mice exhibited no change in glucose homeostasis and had normal insulin and high adiponectin levels, whereas male mice had impaired glucose homeostasis, compromised brown adipose tissue structure, and high insulin and low adiponectin levels. Mechanistically, we found that PHB overexpression enhances the cross talk between the mitochondria and the nucleus and facilitates mitochondrial biogenesis. The data suggest a critical role of PHB and adipocyte mitochondria in adipose tissue homeostasis and reveal sex differences in the effect of PHB-induced adipocyte mitochondrial remodeling on whole-body metabolism. Targeting adipocyte mitochondria may provide new therapeutic opportunities for the treatment of obesity, a major risk factor for type 2 diabetes.

Introduction

In addition to the classic role in energy production, mitochondria have tissue-specific functions, especially in white adipose tissue (WAT), which relies on mitochondria for its specialized function (1). Mitochondrial biogenesis is an important process in adipocyte differentiation (2,3). However, the role of adipocyte mitochondria in adipose tissue homeostasis and metabolic regulation is not entirely understood. Obesity is characterized by an increase in adipose tissue mass, and this requires corresponding changes in adipocyte biology, including mitochondrial biogenesis and function, to synthesize and store excess fat. However, obese animal models based on primary alterations in adipocyte mitochondria are not available.

We have reported that prohibitin (PHB [also known as PHB1]) is important in adipocyte differentiation (4). PHB is an evolutionarily conserved protein that functions as a mitochondrial chaperone and plays an important role in mitochondrial biology (5). In humans, the PHB gene has been mapped to chromosome 17q12–q21 (6), and locus 17q21 harbors genes that influence the propensity to accumulate fat in the intra-abdominal area (7). Phb knockdown in Caenorhabditis elegans results in a significant reduction in intestinal fat content (8). Moreover, PHB overexpression in preadipocytes facilitates adipogenesis, whereas PHB silencing attenuates adipogenesis and mitochondrial function (4,9,10). Collectively, this evidence points to a role of PHB in adipose tissue biology; however, the precise mechanism involved remains to be determined.

We hypothesized that the role of PHB in adipogenesis is mediated through mitochondrial biogenesis. To test this hypothesis, we generated transgenic mice overexpressing PHB in adipocytes under the control of the adipocyte protein-2 (aP2) gene promoter. PHB overexpression in adipocytes increased mitochondrial biogenesis and caused obesity in mice. We named these mice Mito-Ob because they develop obesity as a result of adipocyte mitochondrial remodeling. This article reports on the metabolic phenotype of Mito-Ob mice.

Research Design and Methods

Cloning of PHB

The aP2 promoter-containing vector [pBS-aP2 promoter (5.4 kb) polyA] was obtained from Addgene (Cambridge, MA). A full-length PHB clone was obtained from OriGene Technologies (Rockville, MD). PHB clone was digested with Not1 to release the full-length cDNA of PHB, and then PHB cDNA was subcloned into the Not1 site of the pBS-aP2 promoter vector.

Generation of Transgenic Mice

The aP2 promoter containing PHB clone was digested with Sac1 and Kpn1 restriction enzymes to release the fragment containing aP2 promoter with full-length PHB. This DNA was purified and used for pronuclear transfer into zygotes from CD1 mice. Founder animals were identified by PCR amplification of tail genomic DNA using forward primer 5′-GCAGCCCGGGGGATCCACTA-3′ and reverse primer 5′-GCACACGCTCATCAAAGTCCTCTCCGATGCTG-3′. Founder animals were mated with CD1 female mice to establish PHB transgenic mouse lines as per standard procedures. Experiments involving animals were performed as per the study protocols approved by the Institutional Animal Care and Use Committee.

Body Weight and Food Intake

The animals were given normal chow (LabDiet, St. Louis, MO). Body weight of Mito-Ob and wild-type mice was recorded weekly after weaning, and food intake during 3–6 months of age was determined (11).

Physical Activity

Horizontal activity levels were measured using a metabolic cage system (AccuScan, Columbus, OH), and data were collected every 5 min for 24 h (12).

Histology

Adipose tissues from 6-month-old Mito-Ob and wild-type littermates were fixed in buffered formaldehyde and subsequently dehydrated and embedded in paraffin; 5-μm sections were stained with hematoxylin-eosin (13).

Western Immunoblotting

Adipose tissue lysates from Mito-Ob and wild-type mice containing equal amounts of proteins (∼15 μg/lane) were separated by SDS-PAGE and subsequently analyzed by immunoblotting (4,13). MitoBiogenesis Western blotting cocktail (Abcam Inc.) was used to determine succinate dehydrogenase-A (SDH-A) and cytochrome c oxidase-I (COX-I) protein levels in adipose tissue.

Transmission Electron Microscopy

Adipose tissues were excised into small pieces (<1 mm3) and fixed with 2.5% glutaraldehyde in 0.1 mol/L PBS buffer (pH 7.4) for 3 h. Each specimen was postfixed in 1% osmium tetroxide for 1 h before embedding in epon resin. Transmission electron microscopy was performed with a Philips CM10 at 80 kV on ultra-thin sections (100 nm) and stained with uranyl acetate and counterstained with lead citrate.

Mitochondrial DNA

Mitochondrial DNA (mtDNA) copy number in adipose tissue was determined by real-time PCR (14).

Measurement of Adipokines and Hormones

Serum adipokines and hormones were measured with a Bio-Plex Pro Mouse Diabetes Assay and Bio-Plex 200 3D Multiplex Suspension Array System (Bio-Rad, Hercules, CA) per the manufacturer’s protocols.

Glucose and Insulin Tolerance Tests

Glucose and insulin tolerance tests in 6-month-old mice were performed as previously described (13).

Measurement of Cholesterol, Triglyceride, and Free Fatty Acid Levels

Serum cholesterol (Molecular Probes, Eugene, OR), triglyceride, and free fatty acid (FFA) levels were measured by using kits from BioAssay Systems (Hayward, CA). FFA uptake and oxidation were measured by using kits from Abcam Inc.

Statistical Analysis

All statistical analyses were performed with GraphPad Prism 6 software. Experimental results are shown as mean ± SEM. Two-tailed Student unpaired t tests were performed to compare sex-matched Mito-Ob and wild-type littermates unless otherwise indicated. P < 0.05 was considered significant.

Results

Growth Curve and Adipose Tissue Weight

Both male and female Mito-Ob mice initially weighed similarly to their wild-type littermates; however, they started to gain weight beginning at ∼1 month of age and became significantly obese (P < 0.001) by 2–3 months of age (Fig. 1A and B) without any founder effect (Fig. 1A). No difference in food intake was found between Mito-Ob and wild-type mice (Fig. 1B), but a reduction in horizontal activity levels was observed in Mito-Ob mice (Fig. 1B). These results suggest that PHB overexpression in mouse adipocytes leads to obesity development independent of food intake.

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Growth curve and adipose tissue weight in the Mito-Ob mice. A: The top panels show body weight of the Mito-Ob mice and their Wt littermates from three different transgenic lines at 3 months of age (n = 8–10 mice/group). The bottom panels show representative immunoblots of PHB expression levels in the WAT from three different Mito-Ob lines as shown in the top panels (n = 3). B: The left panel shows horizontal activity levels in Mito-Ob mice and their Wt littermates. The middle panel shows food intake in Mito-Ob mice from 3 to 6 months of age (n = 8–12 mice/group). The right panel shows the growth curve of the Mito-Ob mice and their Wt littermates (n = 10–12 mice/group). *P < 0.05, ***P < 0.001 vs. respective Wt mice. C: Adipose tissue weight of 6-month-old mice (n = 8 mice/group). D: The top panels show representative photomicrographs of hematoxylin-eosin–stained WAT from 6-month-old mice (n = 6 mice/group). A crown-like structure, a sign of macrophage infiltration, is indicated with arrowheads. Scale bars = 20 μm. The bottom panels show representative photomicrographs of hematoxylin-eosin–stained BAT from 6-month-old mice (n = 6 mice/group). Large unilocular lipid droplets are shown with asterisks. Scale bars = 20 μm. Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by Student t test between sex-matched Mito-Ob and Wt. NS, not significant; Wt, wild type.

Female Mito-Ob mice accumulated more visceral fat, but less brown adipose tissue (BAT) than male Mito-Ob mice, whereas subcutaneous fat mass increased similarly in Mito-Ob female and male mice (Fig. 1C). Collectively, these data suggest that PHB overexpression in mouse adipocytes leads to increased adipose tissue mass, with sex-related differential effects on brown and visceral fat depots.

Histology of Adipose Tissue

Consistent with an increase in the adipose tissue mass in Mito-Ob mice, adipocyte hypertrophy was apparent in the WAT from Mito-Ob mice (Fig. 1D). In addition, WAT from male Mito-Ob mice showed increased distribution of crown-like structures, a sign of macrophage infiltration (Fig. 1D). Furthermore, male Mito-Ob mice had increased fat accumulation in BAT (Fig. 1D). These data suggest that PHB overexpression in adipocytes leads to adipocyte hypertrophy, implying increased triglyceride synthesis and/or storage in WAT of Mito-Ob mice.

Ultrastructural Analysis of Adipose Tissue

Transmission electron microscopy showed an increase in mitochondrial number and distribution throughout the cytoplasmic rim of white adipocytes in Mito-Ob mice versus wild-type littermates (Fig. 2A). The mitochondria in these adipocytes were predominantly elongated in Mito-Ob mice but round in wild-type mice (Fig. 2A). In contrast, BAT had similar mitochondrial content in Mito-Ob and wild-type mice (Fig. 2B). However, a reduction in mitochondrial size was observed in BAT from Mito-Ob male mice (Fig. 2B).

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Ultrastructural analysis of adipose tissue from the Mito-Ob mice. A: Representative transmission electron micrographs (magnification ×13,500) of WAT showing relative distribution of mitochondria (shown with arrowheads) in adipocytes from Mito-Ob and Wt mice (n = 5 mice/group). The asterisks indicate unilocular lipid droplets, and n indicates the nucleus. Further magnified views are shown in the insets. Scale bars = 1 μm. B: Representative transmission electron micrographs (magnification ×19,000) of BAT showing changes in mitochondrial cristae structure (arrowheads) and larger fat droplet size (asterisks) in Mito-Ob mice compared with Wt mice (n = 5 mice/group). Scale bars = 500 nm. C: Mitochondrial numbers and mtDNA copy numbers in the WAT of Mito-Ob and Wt mice as determined by real-time PCR (n = 5). D: Representative immunoblots and histograms showing the expression levels of SDH-A and COX-I in the adipose tissue of Mito-Ob mice (the ratio of SDH-A or COX-I to β-actin; n = 4 mice/group). E: Representative immunoblots showing the expression level of marker proteins of mitochondrial biogenesis, fission, and fusion (n = 4). *P < 0.05, **P < 0.01, ***P < 0.001 by Student t test. Data are mean ± SEM. M, Mito-Ob; NS, not significant; W, wild type; Wt, wild type.

To confirm mitochondrial biogenesis in the WAT of Mito-Ob mice, we determined mtDNA copy numbers and mitochondrial protein (SDH-A, COX-I, PGC-1α, DNA poly-γ A, mitochondrial transcription factor A [Tfam], etc.) levels. Both were significantly upregulated (P < 0.05–0.001) in Mito-Ob mice (Fig. 2C–E). Collectively, these results suggest that PHB overexpression in adipocytes induces mitochondrial biogenesis.

Systemic Metabolism in Mito-Ob Mice

Only Mito-Ob males were found to have significantly impaired glucose (P < 0.05–0.001) and insulin (P < 0.05–0.01) tolerance (Fig. 3A). Mito-Ob female mice had insulin sensitivity similar to wild-type animals (Fig. 3A). A sign of hepatic steatosis was also found in the liver of Mito-Ob mice (Fig. 3B). The data suggest that obesity in Mito-Ob mice have sex-specific metabolic impairment. Among lipid parameters, serum triglyceride, glycerol, and cholesterol levels were significantly decreased (P < 0.001) in Mito-Ob female mice, whereas FFA levels were significantly increased (P < 0.01) in Mito-Ob male mice (Table 1).

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

The metabolic phenotype of the Mito-Ob mice at 6 months of age. A: GTT (n = 9–12 mice/ group) and ITT (n = 7–9 mice/group) in Mito-Ob mice compared with Wt mice. *P < 0.05, **P < 0.01, ***P < 0.001 by Student t test between Mito-Ob and Wt male mice. Data are mean ± SEM. B: Representative photomicrographs showing hematoxylin-eosin–stained histological sections of liver (top panels, scale bars = 20 μm) and pancreas (bottom panels, scale bars = 50 μm) from Mito-Ob and Wt mice (n = 6 mice/group). C: Representative immunoblots showing expression levels of various lipases in WAT from Mito-Ob and Wt mice (n = 4). β-Actin blot is included as the loading control. Line graphs show insulin-induced FFA uptake by WAT from Mito-Ob and Wt mice. Data are mean ± SEM (n = 4). *Significantly different during entire time course (P < 0.05–0.001). GTT, glucose tolerance test; ITT, insulin tolerance test; NS, not significant; Wt, wild type.

View this table:
  • View inline
  • View popup
Table 1

Serum hormones, adipokines, and lipid profiles in Mito-Ob and wild-type mice at 6 months of age

Serum insulin levels were significantly higher (P < 0.01) in Mito-Ob male mice versus wild-type littermates (Table 1). However, Mito-Ob female mice had insulin levels similar to wild-type littermates (Table 1). Among adipokines, adiponectin levels were increased (P < 0.05) only in Mito-Ob female mice, whereas leptin levels were higher in Mito-Ob male mice (Table 1). Resistin levels were unchanged in Mito-Ob male mice (Table 1).

WAT Lipase Levels in Mito-Ob Mice

We next analyzed the expression levels of adipose triglyceride lipase, hormone-sensitive lipase, and lipoprotein lipase in WAT. Adipose triglyceride lipase and hormone-sensitive lipase were upregulated in both male and female Mito-Ob mice versus wild-type mice, but their levels were higher in Mito-Ob male mice than in Mio-Ob female mice (Fig. 3C). Lipoprotein lipase protein levels were decreased in Mito-Ob male mice but remained unchanged in Mito-Ob female mice (Fig. 3C). FFA uptake was significantly decreased in Mito-Ob male mice (Fig. 3C) without any significant change in fatty acid oxidation (data not shown).

Discussion

The obese phenotype of Mito-Ob mice affirms the emerging notion that PHB and adipocyte mitochondria play a role in the regulation of adipose tissue homeostasis and metabolic regulation (1–4,8–10). However, the metabolic consequences of obesity in Mito-Ob mice are sex specific, suggesting that intrinsic differences exist in the way adipose tissues are regulated and/or respond to obesity development in male and female mice despite a similar underlying cause. The aP2 promoter used in this study is primarily expressed in adipocytes and has been used in similar work (15). In addition, it is expressed in immune cells, such as macrophages (16). However, a similar effect of PHB manipulation in adipocytes in vitro and in vivo (4,8–10) suggests that the phenotype we have observed is most likely due to the role of PHB in adipocytes.

PHB translocates from mitochondria to the nucleus in response to estrogen (17). In addition, PHB has been associated with the function of Tfam and nuclear factor-like 2 (Nrf-2) (18,19). Tfam plays an important role in mitochondrial biology, and Nrf-2 regulates transcription of nuclear-encoded mitochondrial proteins (18,20). This evidence along with the upregulation of mitochondrial biogenesis found in the WAT of Mito-Ob mice suggest a potential role of PHB in the mitonuclear cross talk required for mitochondrial biogenesis. Furthermore, the upregulation mitochondrial biogenesis markers in the WAT of Mito-Ob mice suggests that PHB indeed plays a role in this process. An enhanced mitonuclear cross talk may be the underlying mechanism behind increased mitochondrial biogenesis in the WAT of Mito-Ob mice.

Men and women have distinct distributions of body fat, where subcutaneous fat tends to be predominant in females and visceral fat is predominant in males (21). It is the visceral fat that is related to obesity and its complications (21). However, the paradox of normal insulin sensitivity along with increased visceral obesity in the Mito-Ob female mice suggests that it is not the visceral obesity per se but the functional status of the adipose tissue, such as the dynamics of lipid handling and adipokine secretion, that leads to obesity-associated disorders. For example, a differential regulation of adiponectin in Mito-Ob male and female mice could be related to the different metabolic status because adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation (22), and adiponectin secretion has been reported to correlate with mitochondrial function (23). In this context, it should be noted that estrogens, which have protective effects against obesity, also play a role in mitochondrial biogenesis (21,24,25). However, it is not known whether the role of estrogen in mitochondrial biology is linked to its protective effect against obesity. The Mito-Ob female mice provide a unique opportunity to dissect the relationship among estrogen, PHB, and mitochondria in adipose tissue biology and metabolic regulation.

In summary, the obese phenotype and sex-specific metabolic dysregulation in Mito-Ob mice establish for the first time to our knowledge an important role of PHB in adipose tissue biology in mammals. It is expected that Mito-Ob mice will prove a valuable tool for obesity research. We anticipate that Mito-Ob mice will help to better define the sex differences in obesity and associated health problems and the role of adipose tissue mitochondria.

Article Information

Acknowledgments. The authors thank Tooru M. Mizuno and Pei San Lew, Department of Physiology, University of Manitoba, for help with horizontal activity measurement.

Funding. The authors were supported by the Natural Sciences and Engineering Research Council of Canada, Manitoba Health Research Council (MHRC), and Canada Foundation for Innovation. G.P.P.-M. is a recipient of an MHRC Postdoctoral Fellowship Award.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Authors Contributions. S.R.A. generated the aP2-PHB construct, performed genotyping, measured hormones and adipokines levels in serum, and contributed to all experiments involving animals. K.H.N. performed real-time PCR, measured lipid parameters, and contributed to all experiments involving animals. G.P.P.-M. analyzed protein samples. W.W. performed histological analyses. B.L.G.N. contributed to the data interpretation and writing of the manuscript. S.M. contributed to the experimental design, data analysis and interpretation, and writing of the manuscript. S.M. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data.

Prior Presentation. This study was presented in abstract form at the 3rd Scientific Sessions of the Society for Mitochondrial Research and Medicine, Bengaluru, India, 19–20 December 2013.

Footnotes

  • This article contains Supplementary Data online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db13-1807/-/DC1.

  • Received November 26, 2013.
  • Accepted May 19, 2014.
  • © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

References

  1. ↵
    1. Wilson-Fritch L,
    2. Nicoloro S,
    3. Chouinard M,
    4. et al
    . Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 2004;114:1281–1289pmid:15520860
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Lu RH,
    2. Ji H,
    3. Chang ZG,
    4. Su SS,
    5. Yang GS
    . Mitochondrial development and the influence of its dysfunction during rat adipocyte differentiation. Mol Biol Rep 2010;37:2173–2182pmid:19693701
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. De Pauw A,
    2. Tejerina S,
    3. Raes M,
    4. Keijer J,
    5. Arnould T
    . Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 2009;175:927–939pmid:19700756
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Ande SR,
    2. Xu Z,
    3. Gu Y,
    4. Mishra S
    . Prohibitin has an important role in adipocyte differentiation. Int J Obes (Lond) 2012;36:1236–1244pmid:22124450
    OpenUrlCrossRefPubMed
  5. ↵
    1. Merkwirth C,
    2. Langer T
    . Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 2009;1793:27–32pmid:18558096
    OpenUrlPubMedWeb of Science
  6. ↵
    1. Sato T,
    2. Saito H,
    3. Swensen J,
    4. et al
    . The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res 1992;52:1643–1646pmid:1540973
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Pérusse L,
    2. Rice T,
    3. Chagnon YC,
    4. et al
    . A genome-wide scan for abdominal fat assessed by computed tomography in the Québec Family Study. Diabetes 2001;50:614–621pmid:11246882
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Artal-Sanz M,
    2. Tavernarakis N
    . Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C. elegans. Nature 2009;461:793–797pmid:19812672
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Liu D,
    2. Lin Y,
    3. Kang T,
    4. et al
    . Mitochondrial dysfunction and adipogenic reduction by prohibitin silencing in 3T3-L1 cells. PLoS One 2012;7:e34315pmid:22479600
    OpenUrlCrossRefPubMed
  10. ↵
    1. Kang T,
    2. Lu W,
    3. Xu W,
    4. et al
    . MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells. J Biol Chem 2013;288:34394–34402pmid:24133204
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Chen L,
    2. Nyomba BL
    . Effects of prenatal alcohol exposure on glucose tolerance in the rat offspring. Metabolism 2003;52:454–462pmid:12701058
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Kim ER,
    2. Leckstrom A,
    3. Mizuno TM
    . Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice. Behav Brain Res 2008;194:66–71pmid:18639588
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Nguyen KH,
    2. Yao XH,
    3. Moulik S,
    4. Mishra S,
    5. Nyomba BL
    . Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion. Endocrinology 2011;152:2184–2196pmid:21447640
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Kelly RDW,
    2. Mahmud A,
    3. McKenzie M,
    4. Trounce IA,
    5. St John JC
    . Mitochondrial DNA copy number is regulated in a tissue specific manner by DNA methylation of the nuclear-encoded DNA polymerase gamma A. Nucleic Acids Res 2012;40:10124–10138pmid:22941637
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Kusminski CM,
    2. Holland WL,
    3. Sun K,
    4. et al
    . MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 2012;18:1539–1549pmid:22961109
    OpenUrlCrossRefPubMed
  16. ↵
    1. Fu Y,
    2. Luo L,
    3. Luo N,
    4. Garvey WT
    . Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis 2006;188:102–111pmid:16313911
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Dong P,
    2. Jiang L,
    3. Liu J,
    4. et al
    . Induction of paclitaxel resistance by ERα mediated prohibitin mitochondrial-nuclear shuttling. PLoS One 2013;8:e83519pmid:24376711
    OpenUrlCrossRefPubMed
  18. ↵
    1. Kasashima K,
    2. Sumitani M,
    3. Satoh M,
    4. Endo H
    . Human prohibitin 1 maintains the organization and stability of the mitochondrial nucleoids. Exp Cell Res 2008;314:988–996pmid:18258228
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Theiss AL,
    2. Vijay-Kumar M,
    3. Obertone TS,
    4. et al
    . Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice. Gastroenterology 2009;137:199–208, e1–e6pmid:19327358
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Athale J,
    2. Ulrich A,
    3. Chou Macgarvey N,
    4. et al
    . Nrf2 promotes alveolar mitochondrial biogenesis and resolution of lung injury in Staphylococcus aureus pneumonia in mice. Free Radic Biol Med 2012;53:1584–1594pmid:22940620
    OpenUrlCrossRefPubMed
  21. ↵
    1. Björntorp P
    . The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996;20:291–302pmid:8680455
    OpenUrlPubMedWeb of Science
  22. ↵
    1. Fu Y,
    2. Luo N,
    3. Klein RL,
    4. Garvey WT
    . Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 2005;46:1369–1379pmid:15834118
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Wang CH,
    2. Wang CC,
    3. Huang HC,
    4. Wei YH
    . Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes. FEBS J 2013;280:1039–1050pmid:23253816
    OpenUrlCrossRefPubMed
  24. ↵
    1. Chen JQ,
    2. Cammarata PR,
    3. Baines CP,
    4. Yager JD
    . Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim Biophys Acta 2009;1793:1540–1570pmid:19559056
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    1. Yao J,
    2. Zhao L,
    3. Mao Z,
    4. et al
    . Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. Brain Res 2013;1514:128–141pmid:23428542
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Diabetes: 63 (11)

In this Issue

November 2014, 63(11)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prohibitin Overexpression in Adipocytes Induces Mitochondrial Biogenesis, Leads to Obesity Development, and Affects Glucose Homeostasis in a Sex-Specific Manner
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Prohibitin Overexpression in Adipocytes Induces Mitochondrial Biogenesis, Leads to Obesity Development, and Affects Glucose Homeostasis in a Sex-Specific Manner
Sudharsana R. Ande, K. Hoa Nguyen, G. Pauline Padilla-Meier, Wahida Wahida, B.L. Grégoire Nyomba, Suresh Mishra
Diabetes Nov 2014, 63 (11) 3734-3741; DOI: 10.2337/db13-1807

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Prohibitin Overexpression in Adipocytes Induces Mitochondrial Biogenesis, Leads to Obesity Development, and Affects Glucose Homeostasis in a Sex-Specific Manner
Sudharsana R. Ande, K. Hoa Nguyen, G. Pauline Padilla-Meier, Wahida Wahida, B.L. Grégoire Nyomba, Suresh Mishra
Diabetes Nov 2014, 63 (11) 3734-3741; DOI: 10.2337/db13-1807
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Research Design and Methods
    • Results
    • Discussion
    • Article Information
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance
  • Relative Adipose Tissue Failure in Alström Syndrome Drives Obesity-Induced Insulin Resistance
  • Ablation of AMPK-Related Kinase MPK38/MELK Leads to Male-Specific Obesity in Aged Mature Adult Mice
Show more Metabolism

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.